Sustainable Bio-based Chemicals Will Capture Asia And Latin America

Published
02 Sep 24
Updated
14 Aug 25
AnalystConsensusTarget's Fair Value
US$65.11
16.9% undervalued intrinsic discount
14 Aug
US$54.11
Loading
1Y
-37.1%
7D
1.9%

Author's Valuation

US$65.1

16.9% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on08 May 25
Fair value Decreased 11%

Shared on30 Apr 25
Fair value Increased 2.13%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25
Fair value Decreased 2.93%

AnalystConsensusTarget has increased revenue growth from -0.5% to -0.4%.

Shared on17 Apr 25
Fair value Decreased 2.70%

AnalystConsensusTarget has decreased revenue growth from -0.2% to -0.5%.

Shared on09 Apr 25
Fair value Decreased 2.50%

AnalystConsensusTarget has decreased revenue growth from 0.0% to -0.2%.

Shared on02 Apr 25
Fair value Decreased 2.68%

AnalystConsensusTarget has increased revenue growth from -0.0% to 0.0%.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Decreased 2.28%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on11 Mar 25
Fair value Increased 21%

AnalystConsensusTarget has decreased revenue growth from 0.2% to -0.0%, increased profit margin from 9.9% to 15.1% and decreased future PE multiple from 23.3x to 13.2x.